AGENUS INC Other Noncash Expense
AGENUS INC (AGEN) reported Other Noncash Expense of $1.45 million for the 12-month period ending 2024-12-31, per its 10-K filed 2025-03-17.
Financial Statements › Cash Flow › Operating Activities
us-gaap:OtherNoncashExpense · last filed 2025-03-17
- AGENUS INC other noncash expense for the quarter ending 2023-12-31 was $1.43M.
- AGENUS INC other noncash expense for the quarter ending 2023-09-30 was $332.00K.
- AGENUS INC other noncash expense for the quarter ending 2015-06-30 was $299.35K, a 94.71% increase year-over-year.
- AGENUS INC other noncash expense for the quarter ending 2015-03-31 was $203.35K, a 32.78% increase year-over-year.
- AGENUS INC other noncash expense for fiscal 2024 was $1.45M, a 27.65% decline from fiscal 2023.
- AGENUS INC other noncash expense for fiscal 2023 was $2.01M.
- AGENUS INC other noncash expense for fiscal 2014 was $619.85K, a 65.96% decline from fiscal 2013.
- AGENUS INC other noncash expense for fiscal 2013 was $1.82M, a 42.04% decline from fiscal 2012.
| Period end | Other Noncash Expense 3 month | Other Noncash Expense 3 month as first filed | Other Noncash Expense 6 month | Other Noncash Expense 6 month as first filed | Other Noncash Expense 9 month | Other Noncash Expense 9 month as first filed | Other Noncash Expense 12 month | Other Noncash Expense 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2024-12-31 | $1.45M 10-K · filed 2025-03-17 | |||||||
| 2023-12-31 | $1.43M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-17 | $1.76M derived: sum of 2 quarters · filed 2025-03-17 | $2.01M 10-K · filed 2025-03-17 | |||||
| 2023-09-30 | $332.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $581.00K 10-Q · filed 2023-11-09 | ||||||
| 2023-06-30 | $249.00K 10-Q · filed 2023-08-08 | |||||||
| 2015-06-30 | $299.35K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-03 | $502.69K 10-Q · filed 2015-08-03 | $660.88K derived: sum of 3 quarters · filed 2015-08-03 | $815.66K derived: sum of 4 quarters · filed 2015-08-03 | ||||
| 2015-03-31 | $203.35K 10-Q · filed 2015-05-01 | $361.54K derived: sum of 2 quarters · filed 2015-05-01 | $516.31K derived: sum of 3 quarters · filed 2015-05-01 | $670.05K derived: sum of 4 quarters · filed 2015-08-03 | ||||
| 2014-12-31 | $158.19K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-16 | $312.96K derived: sum of 2 quarters · filed 2015-03-16 | $466.70K derived: sum of 3 quarters · filed 2015-08-03 | $619.85K 10-K · filed 2015-03-16 | ||||
| 2014-09-30 | $154.77K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-10-31 | $308.51K derived: sum of 2 quarters · filed 2015-08-03 | $461.65K 10-Q · filed 2014-10-31 | $606.01K derived: sum of 4 quarters · filed 2015-08-03 | ||||
| 2014-06-30 | $153.74K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-03 | $306.88K 10-Q · filed 2015-08-03 | $451.24K derived: sum of 3 quarters · filed 2015-08-03 | $585.95K derived: sum of 4 quarters · filed 2015-08-03 | ||||
| 2014-03-31 | $153.15K 10-Q · filed 2015-05-01 | $297.51K derived: sum of 2 quarters · filed 2015-05-01 | $432.21K derived: sum of 3 quarters · filed 2015-05-01 | $1.53M derived: sum of 4 quarters · filed 2015-05-01 | ||||
| 2013-12-31 | $144.36K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-16 | $279.06K derived: sum of 2 quarters · filed 2015-03-16 | $1.37M derived: sum of 3 quarters · filed 2015-03-16 | $1.82M 10-K · filed 2015-03-16 | ||||
| 2013-09-30 | $134.70K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-10-31 | $1.23M derived: sum of 2 quarters · filed 2014-10-31 | $1.68M 10-Q · filed 2014-10-31 | $2.11M derived: sum of 4 quarters · filed 2015-03-16 | ||||
| 2013-06-30 | $1.09M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-01 | $1.54M 10-Q · filed 2014-08-01 | $1.97M derived: sum of 3 quarters · filed 2015-03-16 | $2.39M derived: sum of 4 quarters · filed 2015-03-16 | ||||
| 2013-03-31 | $448.64K 10-Q · filed 2014-05-09 | $881.39K derived: sum of 2 quarters · filed 2015-03-16 | $1.30M derived: sum of 3 quarters · filed 2015-03-16 | $3.20M derived: sum of 4 quarters · filed 2015-03-16 | ||||
| 2012-12-31 | $432.76K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-16 | $850.20K derived: sum of 2 quarters · filed 2015-03-16 | $2.75M derived: sum of 3 quarters · filed 2015-03-16 | $3.14M 10-K · filed 2015-03-16 | ||||
| 2012-09-30 | $417.44K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-08 | $2.32M derived: sum of 2 quarters · filed 2013-11-08 | $2.71M 10-Q · filed 2013-11-08 | -$2.71M 10-Q · filed 2012-11-07 | $9.23M derived: sum of 4 quarters · filed 2014-03-07 | |||
| 2012-06-30 | $1.90M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-09 | $2.29M 10-Q · filed 2013-08-09 | -$2.29M 10-Q · filed 2012-08-08 | $8.81M derived: sum of 3 quarters · filed 2014-03-07 | $8.45M derived: sum of 4 quarters · filed 2014-03-07 | |||
| 2012-03-31 | $388.64K 10-Q · filed 2013-05-10 | -$388.64K 10-Q · filed 2012-05-09 | $6.91M derived: sum of 2 quarters · filed 2014-03-07 | $6.54M derived: sum of 3 quarters · filed 2014-03-07 | $4.81M derived: sum of 4 quarters · filed 2014-03-07 | |||
| 2011-12-31 | $6.52M derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-07 | $6.16M derived: sum of 2 quarters · filed 2014-03-07 | $4.42M derived: sum of 3 quarters · filed 2014-03-07 | $4.17M 10-K · filed 2014-03-07 | -$4.17M 10-K · filed 2012-03-06 | |||
| 2011-09-30 | -$362.06K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-07 | -$2.10M derived: sum of 2 quarters · filed 2012-11-07 | -$2.35M 10-Q · filed 2012-11-07 | $3.92M derived: sum of 4 quarters · filed 2013-03-18 | ||||
| 2011-06-30 | -$1.74M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-08 | -$1.99M 10-Q · filed 2012-08-08 | $4.28M derived: sum of 3 quarters · filed 2013-03-18 | $3.98M derived: sum of 4 quarters · filed 2013-03-18 | ||||
| 2011-03-31 | -$252.10K 10-Q · filed 2012-05-09 | $6.02M derived: sum of 2 quarters · filed 2013-03-18 | $5.71M derived: sum of 3 quarters · filed 2013-03-18 | |||||
| 2010-12-31 | $6.27M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-18 | $5.97M derived: sum of 2 quarters · filed 2013-03-18 | $4.05M 10-K · filed 2013-03-18 | -$4.05M 10-K · filed 2012-03-06 | ||||
| 2010-09-30 | -$304.50K derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-04 | -$2.22M 10-Q · filed 2011-11-04 | ||||||
| 2010-06-30 | -$1.91M 10-Q · filed 2011-08-05 | |||||||
| 2009-12-31 | -$4.01M 10-K · filed 2012-03-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| C4 Therapeutics, Inc. (CCCC) | United States | $0.373B | -5.65 |
| FENNEC PHARMACEUTICALS INC. (FENC) | United States | $0.371B | -115.85 |
| Surrozen, Inc./DE (SRZN) | United States | $0.395B | |
| Zura Bio Ltd (ZURA) | $0.398B | -6.56 | |
| Artiva Biotherapeutics, Inc. (ARTV) | United States | $0.367B | |
| Cabaletta Bio, Inc. (CABA) | United States | $0.365B | -2.81 |
| Scribe Therapeutics, Inc. (SCTX) | United States | $0.410B | |
| Ocugen, Inc. (OCGN) | United States | $0.343B | -6.34 |
| Editas Medicine, Inc. (EDIT) | United States | $0.424B | -4.29 |
| Kyverna Therapeutics, Inc. (KYTX) | United States | $0.434B | -3.60 |